Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP-Study: Alendronate vs Alfacalcidol in GIOP
NCT00138983Phase 3Completed
- Start
- May 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of alendronate, alfacalcidol in glucocorticoid-induced osteoporosis (GIOP). Started May 2000; status: completed.
02
Drugs
alendronatealfacalcidol
03
Conditions
glucocorticoid-induced osteoporosis (GIOP)
Beyond the preview
Go deeper on NCT00138983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00138983.